Epizyme Stock Gains On Potential $310M Pact With HUTCHMED For Cancer-Focused Tazverik In Greater China
Epizyme Inc (NASDAQ:EPZM) and HUTCHMED (China) Limited (NASDAQ:HCM) have collaborated to research, develop, manufacture, and commercialize Tazverik (tazemetostat) in Greater China, including mainland…